✦ LIBER ✦

Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?

✍ Scribed by Roger Yazbeck; Gordon S. Howarth; Catherine A. Abbott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin-Like Growth Factor-1 Is Not Esse

✍ Prue Pereira–Fantini; Sarah Thomas; Julie E. Bines 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Treatment of inflammatory bowel disease

✍ Karim Alavi; Marshall Z Schwartz; Juan P Palazzo; Rajeev Prasad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 115 KB

660 Insulin-Like Growth Factor Binding P

✍ Yamada, Kaori; Imam, Nuvair A.; Pintar, John E.; Brubaker, Patricia L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

867 The Intestinal Epithelial Insulin-Li

✍ Katherine J. Rowland; Shivangi Trivedi; Patricia L. Brubaker 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Intestinal Epithelial Insulin-Like Growt

✍ Katherine J. Rowland; Daiyoon Lee; Ken Wan; Patricia L. Brubaker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 512 KB

P021 Glucagon-like peptide-2 modulates t

✍ C.T. Tee; S. Peake; D. Bernardo; E. Mann; J. Landy; N. Daulatzai; K. Wallis; S.M 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 55 KB